JP2017520567A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017520567A5 JP2017520567A5 JP2016575085A JP2016575085A JP2017520567A5 JP 2017520567 A5 JP2017520567 A5 JP 2017520567A5 JP 2016575085 A JP2016575085 A JP 2016575085A JP 2016575085 A JP2016575085 A JP 2016575085A JP 2017520567 A5 JP2017520567 A5 JP 2017520567A5
- Authority
- JP
- Japan
- Prior art keywords
- poly
- copolymer
- acid
- polar
- region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims description 105
- 229920001577 copolymer Polymers 0.000 claims description 42
- 239000002105 nanoparticle Substances 0.000 claims description 30
- 239000002904 solvent Substances 0.000 claims description 25
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 24
- 229920000642 polymer Polymers 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 16
- 239000003431 cross linking reagent Substances 0.000 claims description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 12
- 125000000129 anionic group Chemical group 0.000 claims description 10
- 239000011248 coating agent Substances 0.000 claims description 10
- 238000000576 coating method Methods 0.000 claims description 10
- -1 magnesium halides Chemical class 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 10
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 229920002125 Sokalan® Polymers 0.000 claims description 8
- 238000004132 cross linking Methods 0.000 claims description 8
- IZOOGPBRAOKZFK-UHFFFAOYSA-K gadopentetate Chemical compound [Gd+3].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O IZOOGPBRAOKZFK-UHFFFAOYSA-K 0.000 claims description 8
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims description 8
- 229920001223 polyethylene glycol Polymers 0.000 claims description 8
- 239000002195 soluble material Substances 0.000 claims description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 8
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 claims description 8
- 229960000707 tobramycin Drugs 0.000 claims description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical group CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- 125000002091 cationic group Chemical group 0.000 claims description 6
- 230000002209 hydrophobic effect Effects 0.000 claims description 6
- 239000011259 mixed solution Substances 0.000 claims description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 6
- 229920001485 poly(butyl acrylate) polymer Polymers 0.000 claims description 6
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 6
- 229920001610 polycaprolactone Polymers 0.000 claims description 6
- 229920001400 block copolymer Polymers 0.000 claims description 5
- 229910052751 metal Inorganic materials 0.000 claims description 5
- 239000002184 metal Substances 0.000 claims description 5
- 229920002643 polyglutamic acid Polymers 0.000 claims description 5
- 108010024636 Glutathione Proteins 0.000 claims description 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 claims description 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 4
- 102000016943 Muramidase Human genes 0.000 claims description 4
- 108010014251 Muramidase Proteins 0.000 claims description 4
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 4
- 229920000361 Poly(styrene)-block-poly(ethylene glycol) Polymers 0.000 claims description 4
- 229920000805 Polyaspartic acid Polymers 0.000 claims description 4
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 4
- 108010059993 Vancomycin Proteins 0.000 claims description 4
- 239000003125 aqueous solvent Substances 0.000 claims description 4
- 239000013522 chelant Substances 0.000 claims description 4
- 229920000359 diblock copolymer Polymers 0.000 claims description 4
- SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 claims description 4
- 229960003180 glutathione Drugs 0.000 claims description 4
- 239000004325 lysozyme Substances 0.000 claims description 4
- 235000010335 lysozyme Nutrition 0.000 claims description 4
- 229960000274 lysozyme Drugs 0.000 claims description 4
- 229920006030 multiblock copolymer Polymers 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 239000004149 tartrazine Substances 0.000 claims description 4
- UJMBCXLDXJUMFB-GLCFPVLVSA-K tartrazine Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-GLCFPVLVSA-K 0.000 claims description 4
- 229960000943 tartrazine Drugs 0.000 claims description 4
- 235000012756 tartrazine Nutrition 0.000 claims description 4
- 229910052723 transition metal Inorganic materials 0.000 claims description 4
- 229920000428 triblock copolymer Polymers 0.000 claims description 4
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 claims description 4
- 229960003165 vancomycin Drugs 0.000 claims description 4
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 claims description 4
- 229910052688 Gadolinium Inorganic materials 0.000 claims description 3
- 235000001014 amino acid Nutrition 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 claims description 3
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 claims description 3
- 239000012216 imaging agent Substances 0.000 claims description 3
- GCYXWQUSHADNBF-AAEALURTSA-N preproglucagon 78-108 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 GCYXWQUSHADNBF-AAEALURTSA-N 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- 235000018102 proteins Nutrition 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 229920005604 random copolymer Polymers 0.000 claims description 3
- 150000003384 small molecules Chemical class 0.000 claims description 3
- 229940124597 therapeutic agent Drugs 0.000 claims description 3
- 229960004799 tryptophan Drugs 0.000 claims description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical class [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
- 229920001661 Chitosan Polymers 0.000 claims description 2
- 108020004414 DNA Proteins 0.000 claims description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical class [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 2
- 229920002873 Polyethylenimine Polymers 0.000 claims description 2
- 108010020346 Polyglutamic Acid Proteins 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 2
- 150000001450 anions Chemical class 0.000 claims description 2
- 229960000074 biopharmaceutical Drugs 0.000 claims description 2
- 229920005605 branched copolymer Polymers 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 239000011575 calcium Substances 0.000 claims description 2
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 claims description 2
- 235000011092 calcium acetate Nutrition 0.000 claims description 2
- 239000001639 calcium acetate Substances 0.000 claims description 2
- 229960005147 calcium acetate Drugs 0.000 claims description 2
- 235000011148 calcium chloride Nutrition 0.000 claims description 2
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- 230000009920 chelation Effects 0.000 claims description 2
- WYYQVWLEPYFFLP-UHFFFAOYSA-K chromium(3+);triacetate Chemical group [Cr+3].CC([O-])=O.CC([O-])=O.CC([O-])=O WYYQVWLEPYFFLP-UHFFFAOYSA-K 0.000 claims description 2
- 229920000578 graft copolymer Polymers 0.000 claims description 2
- 150000004820 halides Chemical class 0.000 claims description 2
- 229960001340 histamine Drugs 0.000 claims description 2
- 229920002674 hyaluronan Polymers 0.000 claims description 2
- 229960003160 hyaluronic acid Drugs 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical class Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 239000011777 magnesium Substances 0.000 claims description 2
- 235000011147 magnesium chloride Nutrition 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 238000005191 phase separation Methods 0.000 claims description 2
- 239000004584 polyacrylic acid Substances 0.000 claims description 2
- 108010064470 polyaspartate Proteins 0.000 claims description 2
- 229920001155 polypropylene Polymers 0.000 claims description 2
- 230000000087 stabilizing effect Effects 0.000 claims description 2
- 150000003624 transition metals Chemical class 0.000 claims description 2
- 150000001242 acetic acid derivatives Chemical class 0.000 claims 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- 235000003704 aspartic acid Nutrition 0.000 claims 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 230000001376 precipitating effect Effects 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462016363P | 2014-06-24 | 2014-06-24 | |
| US62/016,363 | 2014-06-24 | ||
| PCT/US2015/036060 WO2015200054A2 (en) | 2014-06-24 | 2015-06-16 | Process for encapsulating soluble biologics, therapeutics, and imaging agents |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019126795A Division JP7019195B2 (ja) | 2014-06-24 | 2019-07-08 | 可溶性生物製剤、治療薬およびイメージング剤をカプセル化するためのプロセス |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017520567A JP2017520567A (ja) | 2017-07-27 |
| JP2017520567A5 true JP2017520567A5 (cg-RX-API-DMAC7.html) | 2019-01-24 |
| JP6554493B2 JP6554493B2 (ja) | 2019-07-31 |
Family
ID=54938922
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016575085A Active JP6554493B2 (ja) | 2014-06-24 | 2015-06-16 | 可溶性生物製剤、治療薬およびイメージング剤をカプセル化するためのプロセス |
| JP2019126795A Active JP7019195B2 (ja) | 2014-06-24 | 2019-07-08 | 可溶性生物製剤、治療薬およびイメージング剤をカプセル化するためのプロセス |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019126795A Active JP7019195B2 (ja) | 2014-06-24 | 2019-07-08 | 可溶性生物製剤、治療薬およびイメージング剤をカプセル化するためのプロセス |
Country Status (5)
| Country | Link |
|---|---|
| US (4) | US10231937B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4299058A3 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6554493B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2015280417B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015200054A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015200054A2 (en) | 2014-06-24 | 2015-12-30 | The Trustees Of Princeton University | Process for encapsulating soluble biologics, therapeutics, and imaging agents |
| WO2017112828A1 (en) * | 2015-12-22 | 2017-06-29 | The Trustees Of Princeton University | Process for encapsulating soluble biologics, therapeutics, and imaging agents |
| WO2019050969A1 (en) * | 2017-09-06 | 2019-03-14 | Prud'homme, Robert, K. | FORMULATIONS OF DIHYDROMYRICETIN NANOPARTICLES |
| WO2019055539A1 (en) | 2017-09-12 | 2019-03-21 | Prudhomme Robert K | CELLULOSIC POLYMER NANOPARTICLES AND METHODS OF FORMING THE SAME |
| JP2021501753A (ja) | 2017-11-03 | 2021-01-21 | ザ・トラスティーズ・オブ・プリンストン・ユニバーシティThe Trustees Of Princeton University | 徐放性ナノキャリア製剤を形成するための疎水性イオン対化およびフラッシュナノ沈殿 |
| US11214672B2 (en) | 2018-01-19 | 2022-01-04 | The Trustees Of Princeton University | Hybrid polymer-inorganic nanocolloids and methods of making them |
| EP3517879B1 (en) | 2018-01-25 | 2020-09-09 | Valeo Vyminiky Tepla, s.r.o. | Feeding plate for heat exchanger |
| WO2019227169A1 (en) * | 2018-05-31 | 2019-12-05 | The University Of Queensland | Core-shell polymer nanoparticle |
| CN108938593B (zh) * | 2018-07-16 | 2021-06-08 | 中山大学 | 一种脂质包裹固体药物纳米颗粒的制备方法 |
| WO2020018890A1 (en) * | 2018-07-19 | 2020-01-23 | Prudhomme Robert K | Triblock copolymer stabilizers for the formation of nanoparticles encapsulating soluble biologics, therapeutics, and imaging agents |
| US11731099B2 (en) | 2018-07-20 | 2023-08-22 | The Trustees Of Princeton University | Method for controlling encapsulation efficiency and burst release of water soluble molecules from nanoparticles and microparticles produced by inverse flash nanoprecipitation |
| US20200147032A1 (en) | 2018-11-14 | 2020-05-14 | Robert K. Prud'homme | Dihydromyricetin hot melt extrusion formulations and methods for forming them |
| US20220211637A1 (en) * | 2019-05-09 | 2022-07-07 | The Trustees Of Princeton University | Random copolymer stabilized nanoparticles encapsulating soluble hydrophilic compounds |
| US12296045B2 (en) | 2019-05-24 | 2025-05-13 | President And Fellows Of Harvard College | Copolymers for stabilizing emulsions and/or forming interfacial films, and methods thereof |
| MX2021015457A (es) | 2019-06-14 | 2022-04-06 | Univ Princeton | Formulaciones de dihidromiricetina y un permeabilizante. |
| WO2021046078A1 (en) | 2019-09-04 | 2021-03-11 | The Trustees Of Princeton University | Comb polymer and block copolymer stabilized nanoparticles encapsulating nucleic acids and other soluble hydrophilic compounds |
| US12486245B2 (en) | 2019-10-21 | 2025-12-02 | The Trustees Of Princeton University | Sequential multi-step flash nanoprecipitation for the formation of nanoparticles with high core loadings |
| US20210169818A1 (en) * | 2019-11-15 | 2021-06-10 | Xuefei BAI | Transdermal Delivery System |
| US11925705B2 (en) * | 2021-09-16 | 2024-03-12 | The Curators Of The University Of Missouri | Method for continuous fabrication of multi-functional nanogels |
| WO2023122331A2 (en) * | 2021-12-23 | 2023-06-29 | Optimeos Life Sciences, Inc. | Nanoparticles and methods of production for the encapsulation of nucleic acids |
| WO2025199353A1 (en) * | 2024-03-21 | 2025-09-25 | Purdue Research Foundation | Nanoparticulate formulations and foliar administration thereof in the treatment and prevention of citrus greening disease |
Family Cites Families (127)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1690760A (en) | 1927-01-05 | 1928-11-06 | Abbott Lab | Enteric coated capsule |
| US4342653A (en) | 1979-02-15 | 1982-08-03 | American Cyanamid Company | Process for the flocculation of suspended solids |
| US4382982A (en) * | 1979-12-07 | 1983-05-10 | Ici Australia Limited | Process for protecting magnetic particles with chromium oxide |
| US5366734A (en) | 1981-02-16 | 1994-11-22 | Zeneca Limited | Continuous release pharmaceutical compositions |
| US4678516A (en) | 1984-10-09 | 1987-07-07 | The Dow Chemical Company | Sustained release dosage form based on highly plasticized cellulose ether gels |
| US4695464A (en) | 1984-10-09 | 1987-09-22 | The Dow Chemical Company | Sustained release dosage form based on highly plasticized cellulose ether gels |
| US4888238A (en) * | 1987-09-16 | 1989-12-19 | James River Corporation | Superabsorbent coated fibers and method for their preparation |
| US4999417A (en) | 1989-03-30 | 1991-03-12 | Nova Pharmaceutical Corporation | Biodegradable polymer compositions |
| WO1994008599A1 (en) | 1992-10-14 | 1994-04-28 | The Regents Of The University Of Colorado | Ion-pairing of drugs for improved efficacy and delivery |
| US5565215A (en) | 1993-07-23 | 1996-10-15 | Massachusettes Institute Of Technology | Biodegradable injectable particles for imaging |
| US6165976A (en) | 1994-06-23 | 2000-12-26 | Astra Aktiebolag | Therapeutic preparation for inhalation |
| AU3649697A (en) | 1996-06-27 | 1998-01-14 | G.D. Searle & Co. | Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications |
| US5851579A (en) | 1996-10-28 | 1998-12-22 | Eastman Chemical Company | Aqueous enteric coating compositions |
| US6730322B1 (en) | 1998-04-30 | 2004-05-04 | Acusphere, Inc. | Matrices formed of polymer and hydrophobic compounds for use in drug delivery |
| US6423345B2 (en) | 1998-04-30 | 2002-07-23 | Acusphere, Inc. | Matrices formed of polymer and hydrophobic compounds for use in drug delivery |
| US6673612B2 (en) | 1999-07-16 | 2004-01-06 | Mirus Corporation | Micellar systems |
| US6291013B1 (en) | 1999-05-03 | 2001-09-18 | Southern Biosystems, Inc. | Emulsion-based processes for making microparticles |
| CA2385989A1 (en) | 1999-09-27 | 2001-04-05 | Andrew Nienstedt | Compositions of tocol-soluble therapeutics |
| FR2811564B1 (fr) | 2000-07-13 | 2002-12-27 | Oreal | Nanoemulsion contenant des polymeres non ioniques, et ses utilisations notamment dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique |
| FR2818905A1 (fr) | 2000-12-28 | 2002-07-05 | Cll Pharma | Compositions pharmaceutiques colloidales micellaires renfermant un principe actif lipophile |
| US7842308B2 (en) | 2001-01-30 | 2010-11-30 | Smithkline Beecham Limited | Pharmaceutical formulation |
| EP1379227A4 (en) | 2001-03-21 | 2007-12-12 | Univ Kentucky Res Found | Microemulsions as precursors to solid nanoparticles |
| US8137699B2 (en) | 2002-03-29 | 2012-03-20 | Trustees Of Princeton University | Process and apparatuses for preparing nanoparticle compositions with amphiphilic copolymers and their use |
| WO2002078674A1 (en) | 2001-03-30 | 2002-10-10 | Trustees Of Princeton University | A process and apparatuses for preparing nanoparticle compositions with amphiphilic copolymers and their use |
| ATE547095T1 (de) | 2001-05-11 | 2012-03-15 | Isis Pharmaceuticals Inc | Antisense-permeationsverstärker |
| EP1401503B1 (en) | 2001-06-22 | 2007-05-09 | Pfizer Products Inc. | Pharmaceutical compositions containing a solid dispersion of a poorly-soluble drug and a solubility-enhancing polymer |
| US8603514B2 (en) | 2002-04-11 | 2013-12-10 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| DE602004014747D1 (de) | 2003-03-26 | 2008-08-14 | Egalet As | Matrixzubereitungen für die kontrollierte darreichung von arzneistoffen |
| JP3999746B2 (ja) | 2003-05-19 | 2007-10-31 | ローム アンド ハース カンパニー | ポリマーナノ粒子の高固形分調製方法 |
| GB0319451D0 (en) | 2003-08-19 | 2003-09-17 | Lonza Biologics Plc | Tropolone assay |
| CA2558916C (en) | 2003-10-20 | 2009-09-22 | William Marsh Rice University | Method to fabricate microcapsules from polymers and charged nanoparticles |
| CN100389766C (zh) | 2003-10-30 | 2008-05-28 | 湖南省中医药研究院 | 二氢杨梅素在制备药物中的应用 |
| US20050228074A1 (en) | 2004-04-05 | 2005-10-13 | Bridgestone Corporation | Amphiphilic polymer micelles and use thereof |
| IL180785A (en) | 2004-07-19 | 2014-03-31 | Celator Pharmaceuticals Inc | Preparations containing particulate structures for the release of active substances |
| US7651982B2 (en) | 2004-08-21 | 2010-01-26 | Halliburton Energy Services, Inc. | Methods and aqueous acid solutions for acidizing wells containing sludging and emulsifying oil |
| US8945629B2 (en) | 2004-09-10 | 2015-02-03 | University Of Wyoming | Nanoparticles for cytoplasmic drug delivery to cancer cells |
| US20060057215A1 (en) * | 2004-09-15 | 2006-03-16 | Raiche Adrian T | Method for the production of nanoparticles and microparticles by ternary agent concentration and temperature alteration induced immiscibility |
| WO2006039369A1 (en) | 2004-09-29 | 2006-04-13 | Alza Corporation | Microparticles and nanoparticles containing a lipopolymer |
| EP1817008B1 (en) | 2004-11-09 | 2020-04-01 | Board of Regents, The University of Texas System | Stabilized hme composition with small drug particles |
| US8007829B2 (en) | 2005-01-19 | 2011-08-30 | William Marsh Rice University | Method to fabricate inhomogeneous particles |
| CA2600085A1 (en) * | 2005-03-09 | 2006-09-14 | Toray Industries, Inc. | Microparticle and pharmaceutical preparation |
| US20060224095A1 (en) | 2005-04-05 | 2006-10-05 | University Of New Hampshire | Biocompatible polymeric vesicles self assembled from triblock copolymers |
| US7723438B2 (en) * | 2005-04-28 | 2010-05-25 | International Business Machines Corporation | Surface-decorated polymeric amphiphile porogens for the templation of nanoporous materials |
| JP2006321763A (ja) * | 2005-05-20 | 2006-11-30 | Hosokawa Funtai Gijutsu Kenkyusho:Kk | 生体適合性ナノ粒子及びその製造方法 |
| US7977024B2 (en) | 2005-12-16 | 2011-07-12 | Xerox Corporation | Solvent-free toner making process using phase inversion |
| US20070231355A1 (en) | 2006-01-23 | 2007-10-04 | L'oreal | Cosmetic composition comprising multiphasic particles |
| CN101848702B (zh) * | 2006-12-01 | 2013-07-17 | 安特里奥公司 | 两亲实体纳米粒子 |
| JP2008297288A (ja) | 2007-06-04 | 2008-12-11 | Toray Ind Inc | 微粒子および製造方法 |
| EP2185626A4 (en) | 2007-08-23 | 2010-09-08 | Medivas Llc | BIODEGRADABLE POLYMERIC GENE TRANSFER COMPOSITIONS CONTAINING CATIONIC ALPHA-AMINO ACIDS |
| US8394914B2 (en) * | 2007-08-24 | 2013-03-12 | Board Of Trustees Of Michigan State University | Functional polyglycolide nanoparticles derived from unimolecular micelles |
| US20090061009A1 (en) | 2007-08-29 | 2009-03-05 | Joseph Schwarz | Composition and Method of Treatment of Bacterial Infections |
| MX2010003642A (es) | 2007-10-12 | 2010-08-09 | Massachusetts Inst Technology | Nanotecnologia de vacuna. |
| US9943490B2 (en) | 2007-11-05 | 2018-04-17 | The Trustees Of Princeton University | Composite flash-precipitated nanoparticles |
| US20110022129A1 (en) | 2007-11-05 | 2011-01-27 | Prud Homme Robert K | Nanoparticles for photodynamic therapy |
| US8974814B2 (en) | 2007-11-12 | 2015-03-10 | California Institute Of Technology | Layered drug delivery polymer monofilament fibers |
| US8729015B2 (en) | 2007-12-21 | 2014-05-20 | Merck Patent Gmbh | Solid lipid microcapsules containing growth hormone inner core microparticles |
| DE102008003615A1 (de) | 2008-01-09 | 2009-07-16 | Magforce Nanotechnologies Ag | Magnetische Transducer |
| WO2009121069A2 (en) | 2008-03-28 | 2009-10-01 | University Of Massachusetts | Compositions and methods for the preparation of nanoemulsions |
| PE20091964A1 (es) | 2008-05-06 | 2010-01-09 | Glaxo Group Ltd | Encapsulacion de agentes biologicamente activos |
| EP2299953B1 (en) | 2008-07-14 | 2017-04-12 | Polypid Ltd. | Sustained-release drug carrier composition |
| US20110256213A1 (en) | 2008-10-15 | 2011-10-20 | The Board Of Trustees Of The University Of Illinois | Phospholipid micellar and liposomal compositions and uses thereof |
| JP5008009B2 (ja) | 2009-02-13 | 2012-08-22 | 独立行政法人科学技術振興機構 | 無機−有機ハイブリッド粒子、及びその製造方法。 |
| US20100305219A1 (en) | 2009-06-02 | 2010-12-02 | The Board Of Trustees Of The University Of Illinois | Emulsions and foams using patchy particles |
| WO2010148653A1 (en) * | 2009-06-26 | 2010-12-29 | Shanghai Jiao Tong University | Polymer vesicles of asymmetric membrane |
| JP5031001B2 (ja) | 2009-07-02 | 2012-09-19 | 学校法人 関西大学 | ナノスフェアの製造方法、ナノスフェア、これを含有する皮膚外用組成物および化粧料 |
| EP2277557B1 (en) | 2009-07-20 | 2014-06-25 | The Procter and Gamble Company | Coated superabsorbent polymer particles and processes therefore |
| WO2011017500A1 (en) | 2009-08-06 | 2011-02-10 | The Trustees Of The University Of Pennsylvania | Amphiphilic janus-dendrimers |
| US8623329B1 (en) | 2009-10-13 | 2014-01-07 | Aerophase, Inc. | Method for the treatment of lung tumors |
| US20110091560A1 (en) | 2009-10-21 | 2011-04-21 | The Burnham Institute For Medical Research | Compositions of nanoparticles and methods of making the same |
| US9115222B2 (en) * | 2009-12-29 | 2015-08-25 | Bridgestone Corporation | Well defined, highly crosslinked nanoparticles and method for making same |
| US20110200828A1 (en) | 2010-02-16 | 2011-08-18 | Biocoat Incorporated | Hydrophilic coatings for medical devices |
| US8288001B1 (en) | 2010-02-16 | 2012-10-16 | Sandia Corporation | Method of making monodisperse nanoparticles |
| US20110229516A1 (en) | 2010-03-18 | 2011-09-22 | The Clorox Company | Adjuvant phase inversion concentrated nanoemulsion compositions |
| WO2011130114A1 (en) * | 2010-04-12 | 2011-10-20 | Iowa State University Research Foundation, Inc. | Nanoparticles and nanoparticle compositions |
| CN107029223A (zh) | 2010-05-26 | 2017-08-11 | 西莱克塔生物科技公司 | 合成纳米载体联合疫苗 |
| US8673359B2 (en) | 2010-07-08 | 2014-03-18 | Brown University | Nanoparticle compositions and methods for improved oral delivery of active agents |
| US20120121510A1 (en) | 2010-11-11 | 2012-05-17 | Brem Rachel F | Localized therapy following breast cancer surgery |
| CA2829629A1 (en) | 2011-03-10 | 2012-09-13 | Board Of Regents, The University Of Texas System | Protein nanoparticle dispersions |
| EP2526927A1 (de) | 2011-05-25 | 2012-11-28 | Justus-Liebig-Universität Gießen | Biokompatible Nano- und Mikropartikel beschichtet mit Stabilisatoren für die pulmonale Applikation |
| FR2976581B1 (fr) | 2011-06-15 | 2013-07-19 | Centre Nat Rech Scient | Materiau auto-assemble a base de polymeres ou d'oligomeres presentant une structure lamellaire non centro-symetrique. |
| WO2013023003A1 (en) * | 2011-08-08 | 2013-02-14 | Rutgers, The State University Of New Jersey | Bioactive amphiphilic polymer stabilized nanoparticles with enhanced stability and activity |
| CN102334609B (zh) | 2011-08-30 | 2013-04-24 | 广州天科生物科技有限公司 | 二氢杨梅素金属配合物的应用 |
| US20130064954A1 (en) | 2011-09-08 | 2013-03-14 | Maria Ochomogo | Microemulsion Concentrates and Nanoemulsion Flavorant Compositions For Food Applications |
| PT3682905T (pt) | 2011-10-03 | 2022-04-07 | Modernatx Inc | Nucleósidos, nucleótidos e ácidos nucleicos modificados e respetivas utilizações |
| US10076496B2 (en) | 2011-11-11 | 2018-09-18 | The Chinese University Of Hong Kong | Engineering of polymer-stabilized nanoparticles for drugs with Log P values below 6 by controlled antisolvent precipitation |
| EP3181128B1 (en) | 2012-01-13 | 2023-03-08 | XSpray Pharma AB (publ) | Nilotinib pharmaceuticalcomposition |
| US9415020B2 (en) | 2012-01-19 | 2016-08-16 | The Johns Hopkins University | Nanoparticle formulations with enhanced mucosal penetration |
| US20140037573A1 (en) | 2012-02-22 | 2014-02-06 | Cerulean Pharma Inc. | Conjugates, particles, compositions, and related methods |
| EP3778696A1 (en) | 2012-04-23 | 2021-02-17 | NanoProteagen Ltd. | Polymeric nanoparticles and a process of preparation thereof |
| US20140256760A1 (en) | 2012-07-09 | 2014-09-11 | Noglo Llc | Reduction or prevention of alcohol reaction with dietary supplements |
| BR112015002055A2 (pt) | 2012-08-24 | 2017-07-04 | Dow Global Technologies Llc | acetato succinato de hidroxialquil metil celulose, composição, dispersão sólida, processo para produzir uma dispersão sólida, forma de dosagem e cápsula de envoltório |
| BR112015005878A2 (pt) | 2012-09-17 | 2017-07-04 | Bind Therapeutics Inc | nanopartículas terapêuticas compreendendo agente terapêutico e métodos de preparar e usar as mesmas |
| EA028569B1 (ru) | 2012-10-24 | 2017-12-29 | Карджилл, Инкорпорейтед | Композиция эмульгатора, содержащего фосфолипиды |
| MX2015004626A (es) | 2012-11-29 | 2015-07-14 | Yeda Res & Dev | Metodos para prevenir metastasis de tumor, tratar y pronosticar cancer e identificar agentes que son inhibidores putativos de metastasis. |
| CN105188905B (zh) | 2013-03-01 | 2019-01-15 | 国立研究开发法人科学技术振兴机构 | 物质包封微囊及其制备方法 |
| JP6456849B2 (ja) | 2013-03-01 | 2019-01-23 | ハーキュリーズ・インコーポレーテッドHercules Incorporated | 高められた性能及び改善された加工性を有する医薬組成物 |
| CA2907915C (en) | 2013-04-03 | 2023-03-07 | Allertein Therapeutics, Llc | Immunomodulatory nanoparticle compositions comprising a plurality of nanoparticles comprising biodegradable or biocompatible polymers and hydrophilic and hydrophobic cellular components |
| DK3033102T4 (da) | 2013-08-13 | 2024-02-26 | Univ Northwestern | Peptidkonjugerede partikler |
| DK3104838T3 (da) | 2014-02-13 | 2020-02-24 | Pfizer | Terapeutiske nanopartikler omfattende et terapeutisk middel og fremgangsmåder til fremstilling og anvendelse deraf |
| WO2015130835A1 (en) | 2014-02-26 | 2015-09-03 | The Trustees Of Princeton University | Polymer nanoparticles |
| US9603830B2 (en) | 2014-05-29 | 2017-03-28 | Thriveplus Llc | Compositions and methods for preventing and recovery from detrimental effects of alcohol consumption |
| CN104042567A (zh) | 2014-06-07 | 2014-09-17 | 福建卫生职业技术学院 | 一种蛇葡萄素纳米胶束及其应用 |
| WO2015200054A2 (en) | 2014-06-24 | 2015-12-30 | The Trustees Of Princeton University | Process for encapsulating soluble biologics, therapeutics, and imaging agents |
| EP3164420A4 (en) | 2014-06-30 | 2018-05-23 | Tarveda Therapeutics, Inc. | Targeted conjugates and particles and formulations thereof |
| CA2965157A1 (en) | 2014-11-25 | 2016-06-02 | Nanocopoeia, Llc | Method of converting a crystalline compound to an amorphous compound, method of increasing the solubility of a crystalline compound in a biorelevant fluid, and nanoparticles that achieve supersaturation |
| AU2016272700A1 (en) | 2015-05-29 | 2017-12-14 | Oculis ehf. | Formation of cyclosporin A/cyclodextrin nanoparticles |
| US20170042823A1 (en) | 2015-08-14 | 2017-02-16 | The Trustees Of Princeton University | Co-encapsulation of antimicrobials and adjuvants in nanocarriers |
| CN105213250A (zh) | 2015-09-08 | 2016-01-06 | 上海应用技术学院 | 一种复配型天然抗菌剂及其制备方法和在化妆品中的应用 |
| WO2017089942A1 (en) | 2015-11-25 | 2017-06-01 | Pfizer Inc. | Therapeutic nanoparticles comprising an antibiotic and methods of making and using same |
| WO2017112828A1 (en) | 2015-12-22 | 2017-06-29 | The Trustees Of Princeton University | Process for encapsulating soluble biologics, therapeutics, and imaging agents |
| EP3199148B1 (en) | 2016-01-28 | 2020-12-02 | Capsugel Belgium NV | Compositions and resulting hard capsules comprising hydrophilic coloring foodstuff concentrates |
| WO2017168426A1 (en) | 2016-03-30 | 2017-10-05 | Vital Beverages Global Inc. | Compositions and methods for selective gi tract delivery |
| CA2972926A1 (en) | 2016-07-11 | 2018-01-11 | Mcmaster University | Brush amphiphilic block copolymers, and self-assembled nanoparticles therefrom |
| US10357529B2 (en) | 2016-11-07 | 2019-07-23 | Rvrs, Llc | Natural formulation for treating hangover |
| CN106750272B (zh) | 2016-12-05 | 2019-05-28 | 福建卫生职业技术学院 | 一种水溶性蛇葡萄素聚合物 |
| WO2019050969A1 (en) | 2017-09-06 | 2019-03-14 | Prud'homme, Robert, K. | FORMULATIONS OF DIHYDROMYRICETIN NANOPARTICLES |
| WO2019055539A1 (en) | 2017-09-12 | 2019-03-21 | Prudhomme Robert K | CELLULOSIC POLYMER NANOPARTICLES AND METHODS OF FORMING THE SAME |
| JP2021501753A (ja) | 2017-11-03 | 2021-01-21 | ザ・トラスティーズ・オブ・プリンストン・ユニバーシティThe Trustees Of Princeton University | 徐放性ナノキャリア製剤を形成するための疎水性イオン対化およびフラッシュナノ沈殿 |
| WO2020018890A1 (en) | 2018-07-19 | 2020-01-23 | Prudhomme Robert K | Triblock copolymer stabilizers for the formation of nanoparticles encapsulating soluble biologics, therapeutics, and imaging agents |
| US11731099B2 (en) | 2018-07-20 | 2023-08-22 | The Trustees Of Princeton University | Method for controlling encapsulation efficiency and burst release of water soluble molecules from nanoparticles and microparticles produced by inverse flash nanoprecipitation |
| US12090235B2 (en) | 2018-09-20 | 2024-09-17 | Modernatx, Inc. | Preparation of lipid nanoparticles and methods of administration thereof |
| US20200147032A1 (en) | 2018-11-14 | 2020-05-14 | Robert K. Prud'homme | Dihydromyricetin hot melt extrusion formulations and methods for forming them |
| US20220211637A1 (en) | 2019-05-09 | 2022-07-07 | The Trustees Of Princeton University | Random copolymer stabilized nanoparticles encapsulating soluble hydrophilic compounds |
| MX2021015457A (es) | 2019-06-14 | 2022-04-06 | Univ Princeton | Formulaciones de dihidromiricetina y un permeabilizante. |
| WO2021046078A1 (en) | 2019-09-04 | 2021-03-11 | The Trustees Of Princeton University | Comb polymer and block copolymer stabilized nanoparticles encapsulating nucleic acids and other soluble hydrophilic compounds |
| US11648211B2 (en) | 2019-09-23 | 2023-05-16 | Northeastern University | Nanoencapsulated combination drug formulations |
| US11241493B2 (en) | 2020-02-04 | 2022-02-08 | Curevac Ag | Coronavirus vaccine |
-
2015
- 2015-06-16 WO PCT/US2015/036060 patent/WO2015200054A2/en not_active Ceased
- 2015-06-16 JP JP2016575085A patent/JP6554493B2/ja active Active
- 2015-06-16 EP EP23209189.2A patent/EP4299058A3/en active Pending
- 2015-06-16 US US15/321,588 patent/US10231937B2/en active Active
- 2015-06-16 EP EP15811879.4A patent/EP3160449B1/en active Active
- 2015-06-16 AU AU2015280417A patent/AU2015280417B2/en active Active
-
2019
- 2019-01-22 US US16/253,850 patent/US11554101B2/en active Active
- 2019-07-08 JP JP2019126795A patent/JP7019195B2/ja active Active
-
2022
- 2022-12-16 US US18/083,458 patent/US12605344B2/en active Active
-
2026
- 2026-03-18 US US19/571,436 patent/US20260216090A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230126007A1 (en) | Nanoparticles encapsulating soluble biologics, therapeutics, and imaging agents | |
| Yang et al. | pH-sensitive micelles self-assembled from amphiphilic copolymer brush for delivery of poorly water-soluble drugs | |
| Li et al. | Facile layer-by-layer self-assembly toward enantiomeric poly (lactide) stereocomplex coated magnetite nanocarrier for highly tunable drug deliveries | |
| JP2020125363A (ja) | 可溶性の生物製剤、治療薬、および造影剤を封入するためのプロセス | |
| Jiang et al. | Drug delivery vehicles based on albumin–polymer conjugates | |
| Huang et al. | Using click chemistry to fabricate ultrathin thermoresponsive microcapsules through direct covalent layer-by-layer assembly | |
| Li et al. | Poly (ethylene glycol) conjugated poly (lactide)-based polyelectrolytes: synthesis and formation of stable self-assemblies induced by stereocomplexation | |
| JP2017149960A5 (cg-RX-API-DMAC7.html) | ||
| US12186436B2 (en) | Triblock copolymer stabilizers for the formation of nanoparticles encapsulating soluble biologics, therapeutics, and imaging agents | |
| Guzman et al. | Eudragit E100 as a drug carrier: the remarkable affinity of phosphate ester for dimethylamine | |
| Watanabe et al. | Microfluidic fabrication of monodisperse polylactide microcapsules with tunable structures through rapid precipitation | |
| US20200023332A1 (en) | Method for controlling encapsulation efficiency and burst release of water soluble molecules from nanoparticles and microparticles produced by inverse flash nanoprecipitation | |
| JP2019512006A5 (cg-RX-API-DMAC7.html) | ||
| Lin et al. | Controllable drug release of electrospun thermoresponsive poly (N‐isopropylacrylamide)/poly (2‐acrylamido‐2‐methylpropanesulfonic acid) nanofibers | |
| JP2019537508A5 (cg-RX-API-DMAC7.html) | ||
| JP2019500403A5 (cg-RX-API-DMAC7.html) | ||
| KR20120101629A (ko) | 폴리아미드 수지 수성 분산체, 그 제조방법, 및 적층체 | |
| JP2021523151A5 (cg-RX-API-DMAC7.html) | ||
| WO2020227350A1 (en) | Random copolymer stabilized nanoparticles encapsulating soluble hydrophilic compounds | |
| Geng et al. | Controllable cooperative self-assembly of PS-b-PAA/PS-b-P4VP mixture by tuning the intercorona interaction | |
| Majcher et al. | Hydrogel synthesis and design | |
| Constantinou et al. | Thermoresponsive multiblock copolymers: Chemistry, properties and applications | |
| Sukhlaaied et al. | Green robust pH–temperature-sensitive maleated poly (vinyl alcohol)-g-gelatin for encapsulated capsaicin | |
| Zhang et al. | From nanofibrous hollow microspheres to nanofibrous hollow discs and nanofibrous shells | |
| CN110114389A (zh) | 含氮原子的聚合物或其盐的乳化液、其制造方法、及粒子的制造方法 |